Clinical Computing PLC
03 June 2004
Ref: PB
3 June 2004
Clinical Computing Plc
Overseas Contract Gains
Clinical Computing Plc ('Clinical Computing' or the 'Company'), the
international developer of clinical information systems for the healthcare
market, announces it has signed two contracts in the US and that it has been
selected as software vendor to a multi-party tender in New Zealand alongside the
subsidiary of a Swedish multi-national company.
The contracts are to supply the Company's new Clinical Vision ('CV4') software
to the renal dialysis market and are worth a total of approximately £375,000.
Both US contracts further extend Clinical Vision's coverage of the US renal
market into the states of California and Texas. The Texas account is a
multi-centre provider that is migrating to Clinical Vision from the Company's
legacy product di-PROTON.
In New Zealand, Clinical Vision was selected as the preferred software solution,
providing the Company with its first site outside of the UK and US for CV4.
Commenting Jack Richardson, CEO of Clinical Computing, said: 'Each of these
contracts provide sales momentum and will accelerate Clinical Vision's position
in the renal software market as a leading clinical software product.'
ENDS
Enquiries:
Clinical Computing plc
Jack Richardson, CEO 001 513 651 3803 ext 114
Joe Marlovits, Finance Director 020 8747 8744 ext 202
Binns & Co PR Ltd
Paul McManus 020 7786 9600
07980 541 893
Peter Binns 07768 392 582
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.